Casi pharmaceuticals announces reverse stock split

Rockville, md. and beijing , may 26, 2022 /prnewswire/ -- casi pharmaceuticals, inc. (nasdaq: casi), a u.s. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced it has filed a certificate of amendment to its amended and restated certificate of incorporation to implement a 1-for-10 reverse stock split that will become effective at 5:00 p.m.
CASI Ratings Summary
CASI Quant Ranking